A case developing minimal change disease during the course of IgG4-related disease

References

• Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68(8):1310–15.
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–51.
   PubMed Web of Science ®Google Scholar
• Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(5):615–26.
   PubMed Web of Science ®Google Scholar
• Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22(7):1343–52.
   PubMed Web of Science ®Google Scholar
• Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014;85(2):251–7.
   PubMed Web of Science ®Google Scholar
• Cornell LD. IgG4-related kidney disease. Semin Diagn Pathol. 2012; 29(4):245–50.
   PubMed Web of Science ®Google Scholar
• Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):1016–23.
   PubMed Web of Science ®Google Scholar
• Katano K, Hayatsu Y, Matsuda T, Miyazaki R, Yamada K, Kawano M, et al. Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. Clin Nephrol. 2007;68(5):308–14.
   PubMed Web of Science ®Google Scholar
• Morimoto J, Hasegawa Y, Fukushima H, Uesugi N, Hisano S, Saito T, Kaneoka H. Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med. 2009;48(3):157–62.
   PubMed Web of Science ®Google Scholar
• Naitoh I, Nakazawa T, Ohara H, Sano H, Ando T, Hayashi K, et al. Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med. 2009;48(23):2003–7.
   PubMed Web of Science ®Google Scholar
• Garg M, Mackay S, Hill PA, Katsoulis J, McLaughlin S, Desmond PV, Chen RY. Leucocytoclastic and renal vasculitis in a patient with autoimmune pancreatitis: new associations. Intern Med J. 2010; 40(5):376–80.
   PubMed Web of Science ®Google Scholar
• Ito K, Yamada K, Mizushima I, Aizu M, Fujii H, Mizutomi K, et al. Henoch-Schonlein purpura nephritis in a patient with IgG4-related disease: a possible association. Clin Nephrol. 2013; 79(3):246–52.
   PubMed Web of Science ®Google Scholar
• Schwartz MM. Membranous glomerulonephritis. In: Jennette C, Olson J. Silva F, Schwartz MM, editors. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia: Lippincott-Raven-Williams & Wilkens; 2007. p. 205–51.
   Google Scholar
• Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol. 1936;12(1):83–97.
   PubMedGoogle Scholar
• Ainsworth SK, Hirsch HZ, Brackett NC Jr, Brissie RM, Williams AV Jr, Hennigar GR. Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Hum Pathol. 1982;13(5):470–8.
   PubMed Web of Science ®Google Scholar
• Nachman PH, Jennette JC, Falk RJ. Primary glomerular disease. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, editors. Brenner and Rector's The Kidney. 9th ed. Philadelphia: Elsevier Saunders; 2012. p. 1103–11.
   Google Scholar
• Herlitz LC, Bomback AS, Stokes MB, Radhakrishnan J, D’Agati VD, Markowitz GS. IgA nephropathy with minimal change disease. Clin J Am Soc Nephrol. 2014;9(6):1033–9.
   PubMed Web of Science ®Google Scholar
• Hogan J, Radhakrishnan J. The treatment of minimal change disease in adults. J Am Soc Nephrol. 2013;24(5):702–11.
   PubMed Web of Science ®Google Scholar
• Abdel-Hafez M, Shimada M, Lee PY, Johnson RJ, Garin EH. Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis. 2009;54(5):945–53.
   PubMed Web of Science ®Google Scholar
• Adrogue HE, Borillo J, Torres L, Kale A, Zhou C, Feig D, et al. Coincident activation of Th2 T cells with onset of the disease and differential expression of GRO-gamma in peripheral blood leukocytes in minimal change disease. Am J Nephrol. 2007;27(3):253–61.
   PubMed Web of Science ®Google Scholar
• Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol. 2007;18(5):1476–85.
   PubMed Web of Science ®Google Scholar
• Kimata H, Fujimoto M, Furusho K. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol. 1995;25(6):1497–501.
   PubMed Web of Science ®Google Scholar
• Cheung W, Wei CL, Seah CC, Jordan SC, Yap HK. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol. 2004;19(6):627–32.
   PubMed Web of Science ®Google Scholar
• Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol. 1999;10(3):529–37.
   PubMed Web of Science ®Google Scholar
• Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, Nakanuma Y. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45(6):1538–46.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Maehara T, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64(1):254–63.
   PubMed Web of Science ®Google Scholar
• Kawano M, Mizushima I, Yamaguchi Y, Imai N, Nakashima H, Nishi S, et al. Immunohistochemical characteristics of IgG4-related tubulointerstitial nephritis: detailed analysis of 20 Japanese cases. Int J Rheumatol. 2012;2012:609795.
   PubMedGoogle Scholar
• Cravedi P, Abbate M, Gagliardini E, Galbusera M, Buelli S, Sabadini E, et al. Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis. 2011;58(2):272–5.
   PubMed Web of Science ®Google Scholar
• Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009;71(2):173–8.
   PubMed Web of Science ®Google Scholar
• Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83(3):455–62.
   PubMed Web of Science ®Google Scholar
• Kanda H, Koya J, Uozaki H, Tateishi S, Sato K, Hagino N, et al. Membranous nephropathy with repeated flares in IgG4-related disease. Clin Kidney J. 2013;6(2):204–7.
   PubMedGoogle Scholar